A multicentre study to determine the in vitro efficacy of flomoxef against extended-spectrum beta-lactamase producing Escherichia coli in Malaysia

Background The high burden of extended-spectrum beta-lactamase-producing (ESBL)-producing Enterobacterales worldwide, especially in the densely populated South East Asia poses a significant threat to the global transmission of antibiotic resistance. Molecular surveillance of ESBL-producing pathogens...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Polly Soo Xi Yap, Chun Wie Chong, Sasheela Ponnampalavanar, Ramliza Ramli, Azian Harun, Tengku Zetty Maztura Tengku Jamaluddin, Anis Ahmed Khan, Soo Tein Ngoi, Yee Qing Lee, Min Yi Lau, Shiang Chiet Tan, Zhi Xian Kong, Jia Jie Woon, Siew Thong Mak, Kartini Abdul Jabar, Rina Karunakaran, Zalina Ismail, Sharifah Azura Salleh, Siti Suraiya Md Noor, Siti Norbaya Masri, Niazlin Mohd Taib, Azmiza Syawani Jasni, Loong Hua Tee, Kin Chong Leong, Victor Kok Eow Lim, Sazaly Abu Bakar, Cindy Shuan Ju Teh
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	PeerJ Inc. 2023-11-01
Rangatū:	PeerJ
Ngā marau:	Extended-spectrum beta-lactamase (ESBL) Escherichia coli Antimicrobial resistance Flomoxef Enterobacterales Surgical site infection
Urunga tuihono:	https://peerj.com/articles/16393.pdf
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!